Viatris Inc.: Seizures trials

The registry lists 20 Seizures studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 17 have results posted.

Phase 1 1Phase 2 1Phase 3 13Phase 4 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.CompletedNCT02072824Phase 3Results posted
• A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.CompletedNCT01747915Phase 3Results posted
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresCompletedNCT01463306Phase 3Results posted
• A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 YearsCompletedNCT01389596Phase 3Results posted
• Once-A-Day Pregabalin For Partial SeizuresCompletedNCT01262677Phase 3Results posted
• Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure FrequencyCompletedNCT00684424Results posted
• A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial SeizuresCompletedNCT00603473Phase 3Results posted
• Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial SeizuresCompletedNCT00596466Phase 3Results posted
• Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial SeizuresCompletedNCT00537940Phase 4Results posted
• Pregabalin Versus Levetiracetam In Partial SeizuresCompletedNCT00537238Phase 3Results posted
• Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial SeizuresTerminatedNCT00524030Phase 3Results posted
• Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset SeizuresCompletedNCT00448916Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset SeizuresCompletedNCT00437281Phase 1/2Results posted
• Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy TrialTerminatedNCT00407797Phase 4Results posted
• An Open-Label Study Of Pregabalin In Subjects With Refractory Partial SeizuresTerminatedNCT00372528Phase 3Results posted
• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or PlaceboCompletedNCT00351611Phase 4Results posted
• Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).CompletedNCT00288639Phase 4Results posted
• Pregabalin In Partial Seizures Extension StudyCompletedNCT00143130Phase 3
• Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.CompletedNCT00141427Phase 4
• Pregabalin Epilepsy Add-On TrialCompletedNCT00141258Phase 3